Mycophenolate PK Simulator
Indication: Organ Transplant Rejection
Population PK simulator for mycophenolic acid (CellCept/Myfortic). Therapeutic drug monitoring with AUC targets.
Drug Overview
Clinical Context
- Molecular Target
- IMPDH
- Drug Class
- Small Molecule
- Therapeutic Area
- Transplant
- Indication
- Organ Transplant Rejection
- Route of Administration
- Oral
Model Information
- Model Type
- PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
PK Parameters
| Parameter | Value |
|---|---|
| Q | 35 L/h (intercompartmental CL) |
| CL | 33 L/h (typical, renal Tx) |
| V1 | 91 L (central volume) |
| V2 | 237 L (peripheral volume) |
| ka | 4.1 h⁻¹ |
| protein binding | 97% (albumin) |
Additional Parameters
| Parameter | Value |
|---|---|
| dose | 500-1500 mg BID (MMF) |
| lag time | 0.21 h |
| AUC target | 30-60 mg·h/L (renal Tx) |
| covariates | CrCL, albumin, ciclosporin dose, sex |
| CL covariate | CL = 33 × (CrCL/48)^(-0.12) × (Alb/30)^(-1.07) × (CSA/450)^0.31 × 1.11^sex |
| V1 covariate | V1 = 91 × (CrCL/48)^(-0.62) × (Alb/30)^(-1.13) |
| enterohepatic recirculation | yes |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for Mycophenolate allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this small molecule following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Mycophenolate PK simulator?
This is a free, interactive pharmacokinetic simulator for Mycophenolate used in Organ Transplant Rejection. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Mycophenolate belong to?
Mycophenolate is classified as a Small Molecule that targets IMPDH. It is used in the Transplant therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of Mycophenolate. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
What is the clearance of Mycophenolate?
The clearance (CL) of Mycophenolate is approximately 33 L/h (typical, renal Tx). Clearance represents the volume of plasma from which drug is completely removed per unit time and is a key determinant of drug exposure and steady-state concentrations.
Related Simulators
Xtandi (Enzalutamide) PK Simulator
Metastatic castration-resistant prostate cancer
Xarelto (Rivaroxaban) PK Simulator
Stroke prevention in atrial fibrillation
Vyndaqel (Tafamidis) PK Simulator
Transthyretin amyloid cardiomyopathy
Verzenio (Abemaciclib) PK Simulator
HR+/HER2- metastatic breast cancer
Trikafta (Elexacaftor/Tezacaftor/Ivacaftor) PK Simulator
Cystic fibrosis
Tagrisso (Osimertinib) PK Simulator
EGFR-mutated non-small cell lung cancer
Ready to Simulate?
Launch the Mycophenolate simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community